TFF Pharmaceuticals Reports Fourth Quarter and Full Year
Pipeline Advancement Continues with Ongoing Phase 2 Studies for Voriconazole and Tacrolimus Programs Partnership Activity Surrounding Thin Film Freezing...
Source: globenewswire.com
📰 Ongoing Phase News
Page 8 - Ongoing Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ongoing Phase. Real-time updates on events, politics, business and more.
GeoVax Announces Key Staff Appointments
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Bicycle Therapeutics plc: Bicycle Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Continued clinical progress across pipeline of Bicycle Toxin Conjugates (BTCs) and Bicycle tumor-targeted immune cell agonists (Bicycle TICAs) Cash of $438.7 million at December 31, 2021 expected to
Source: finanznachrichten.de
Investegate |Orion Oyj Announcements | Orion Oyj: Results from an Ongoing Phase I/II CYPIDES Trial of ODM-208 Presented at ASCO-GU
Investegate announcements from Orion Oyj, Results from an Ongoing Phase I/II CYPIDES Trial of ODM-208 Presented at ASCO-GU
Source: investegate.co.uk
Takeda Pharmaceutical : Submits New Drug Application for Novavax' COVID-19 Vaccine Candidate in Japan
News Release Takeda Submits New Drug Application for Novavax COVID-19 Vaccine Candidate in Japan ... | December 16, 2021
Source: marketscreener.com
GeoVax Announces Initiation of Phase 2 Clinical Trial for COVID-19 Vaccine Booster
Press release content from NewMediaWire. The AP news staff was not involved in its creation.
Source: apnews.com
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at ASH 2021
12.12.2021 - Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today presented positive data from its ongoing global Phase 2 clinical ... Seite 1
United States Hugh Young Rienhoff Jr Jen Hong American Society Of Hematology Imago Biosciences Inc European Hematology Association
Source: wallstreet-online.de
UCB Showcases Key Rheumatology Data at ACR Convergence 2021
/PRNewswire/ -- UCB, a global biopharmaceutical company, today announced new data on its investigational IL-17A and IL-17F inhibitor, bimekizumab, and its TNF...
Bruxelles Capitale Nicole Herga Certolizumab Pegol J Clin Pharmacol Antje Witte Head Of Immunology Medical Affairs
Source: prnewswire.com
DGAP-News: Immunic, Inc. Announces First Psoriasis Patient Enrolled in Ongoing Phase 1 Trial of IMU-935
DGAP-News: Immunic, Inc. / Key word(s): Study Immunic, Inc. Announces First Psoriasis Patient Enrolled in Ongoing Phase 1 Trial of IMU-935 27.10.2021 / 12:30 The issuer is solely
Source: finanznachrichten.de
Genentech's Anti-Amyloid Beta Antibody Gantenerumab Granted FDA Breakthrough Therapy Designation in Alzheimer's Disease
– Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) –– Gantenerumab is the first and only anti-amyloid antibody being investigated for subcutaneous administration in late-stage trials for the treatment of AD –– Ongoing Phase III GRADUATE program with gantenerumab...
Source: pharmiweb.com